Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis relapses and depression.
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab.
Prospective Examination of Anxiety and Depression Before and During Confirmed and Pseudoexacerbations in Patients With Multiple Sclerosis.
Autoimmunity: Rubbing salt in the wound.
Substance Name: Dronabinol
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Study shows promising efficacy for peginterferon beta-1a in multiple sclerosis
Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.
Neuroprotective effects of riluzole in neurotrauma models: a review.
Is multiple sclerosis a proresolution deficiency disorder?
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease.
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation.
Multiple sclerosis: An old drug plays a new trick.
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Laquinimod Halted MS Disability But Not Relapses
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.

Pages